Science Explorer Interactive view Map
Company · Singapore · Singapore

Eli Lilly (Singapore)

Research works
93
▼ 43% vs 2013–17
Citations
5k
53.8 per fractional work
Top-10% rate
22.0%
record average 16.5%
Open access
46%
world 28%

Not ranked overall: Eli Lilly (Singapore) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.90× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 4.41× its world share, 1 worksImmunology and Micro…Neuroscience: 1.35× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.50× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.57× its world share, 0 worksChemistryComputer Science: 1.06× its world share, 1 worksComputer ScienceEngineering: 0.25× its world share, 0 worksEngineeringEnvironmental Science: 0.28× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.59× its world share, 0 worksMaterials ScienceMathematics: 2.46× its world share, 0 worksMathematicsHealth Professions: 0.65× its world share, 0 worksHealth ProfessionsMedicine: 3.01× its world share, 8 worksMedicineVeterinary: 1.30× its world share, 0 worksVeterinaryDecision Sciences: 0.85× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.21× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.02× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 4.4×. Every wedge is a field page.

Which keywords describe research at Eli Lilly (Singapore)?

By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Oxidative Stress, Clinical Guidelines, Diabetes, Biomarkers, Heart Failure and Depression.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Oxidative Stress7▲ 4.3×18 topics
  2. Glycemic Control7▲ 56×4 topics
  3. Insulin Therapy7▲ 67×3 topics
  4. Epidemiology5▲ 1.38×36 topics
  5. Cardiovascular Disease5▲ 4.7×17 topics
  6. Clinical Guidelines5▲ 16×2 topics
  7. Inflammation5▲ 2.1×29 topics
  8. Depression4▲ 6.3×12 topics
  9. Biomarkers4▲ 7.3×8 topics
  10. Diabetes4▲ 8.8×8 topics
  11. Heart Failure4▲ 9.6×7 topics
  12. Cancer4▲ 2.8×23 topics
  13. Metabolic Syndrome4▲ 4.5×13 topics
  14. Type 2 Diabetes4▲ 21×2 topics
  15. Cardiovascular Outcomes3▲ 87×1 topic
  16. Genetics3▲ 4.8×8 topics
  17. Glucose Control3▲ 87×1 topic
  18. Alzheimer's Disease3▲ 12×6 topics
  19. Complications3▲ 6.5×4 topics
  20. Neurodegeneration3▲ 11×5 topics
  21. Neuroimaging3▲ 12×3 topics
  22. Type 1 Diabetes3▲ 33×2 topics
  23. Aging3▲ 5.7×4 topics
  24. Clinical Trials3▲ 4.7×11 topics
  25. Diabetes Mellitus3▲ 13×3 topics
  26. Cognitive Impairment3▲ 12×4 topics
  27. Continuous Glucose Monitoring3▲ 61×1 topic
  28. Hypoglycemia3▲ 61×1 topic
  29. Pharmacokinetics3▲ 10×3 topics
  30. Synaptic Plasticity3▲ 9.2×4 topics
  31. Neuroinflammation2▲ 9.7×3 topics
  32. Medicinal Chemistry2▲ 6.9×5 topics
  33. Primary Care2▲ 6.2×8 topics
  34. Therapeutic Strategies2▲ 27×2 topics
  35. Amyloid Hypothesis2▲ 43×1 topic
  36. Cognitive Function2▲ 11×5 topics
  37. Neurodegenerative Diseases2▲ 10×5 topics
  38. Tau Pathology2▲ 43×1 topic
  39. Dementia2▲ 31×1 topic
  40. Mild Cognitive Impairment2▲ 35×1 topic

Which research topics does Eli Lilly (Singapore) publish most on?

By volume in 2022–2025: Computational Drug Discovery Methods, Pancreatic function and diabetes, Inflammatory Bowel Disease and Alzheimer's disease research and treatments.

  1. 1 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  2. 2 Pancreatic function and diabetes Surgery 1 works
  3. 3 Inflammatory Bowel Disease Genetics 1 works
  4. 4 Alzheimer's disease research and treatments Physiology 1 works
  5. 5 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  6. 6 Dementia and Cognitive Impairment Research Psychiatry and Mental health 0 works
  7. 7 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  8. 8 Microscopic Colitis Epidemiology 0 works
  9. 9 Amyotrophic Lateral Sclerosis Research Neurology 0 works
  10. 10 Total Knee Arthroplasty Outcomes Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.7%not open54.3%

World: 28% of research is openly available.

with international co-authors81.2%domestic only18.8%

World: 19% is written across borders.

How has Eli Lilly (Singapore)'s research output changed?

Output in 2018–2022 was 43% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Singapore

All research institutions in Singapore

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.